Link copied
India's Alivus Lifesciences posts higher third-quarter profit on API boost.
companies :: 2026-01-22 :: source - reuters
By Reuters
(Reuters) - Indian drugmaker Alivus Life Sciences (ALIV.NS), formerly called Glenmark Life Sciences, reported a higher third-quarter profit on Thursday, driven by strong demand in its mainstay active pharmaceutical ingredients (API) business.
More Stories
This week top market trends.
-
Japan’s Stock Market Has Strongest Start to the Year Since 1990
2026-01-06 :: stock :: bloomberg -
Gold rises after topping $5,000 for the first time in 'breathtaking and profoundly scary' rally
2026-01-26 :: commodities :: yahoo finance -
UnitedHealth forecasts 2026 profit slightly above estimates
2026-01-27 :: companies :: reuters -
Crypto Market Mood Weakens With Fear Index At Lowest Level Since December
2026-01-30 :: crypto :: cryptonews -
Chinese Stocks Rally on Growing Tech Bets, Defying Global Selloff
2026-01-21 :: stock :: bloomberg
Recent global market news
-
Global equity funds see record outflows as U.S., China withdrawals surge, TD Securities says
2026-01-23 :: :: reuters
